Upgraded services in Mumbai, plus an existing Chennai PoP, strengthen options for performance, compliance, and connected architectures across India. MUMBAI, India,…
CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to…
RAMALLAH, Palestine, Feb. 15, 2026 /PRNewswire/ — Arab Palestinian Investment Company announced its consolidated preliminary unaudited financial results for 2025. APIC…